Verzenio (abemaciclib) - Eli Lilly
A Study of Abemaciclib (LY2835219) in Healthy Participants (clinicaltrials.gov) - Sep 24, 2026 - P1 | N=15 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting 
Enrollment open
http://clinicaltrials.gov/ct2/show/NCT07818967
 
Sep 24, 2026
 
Prev Next